"use strict";(self.webpackChunkmy_website=self.webpackChunkmy_website||[]).push([[5582],{2339:(e,i,n)=>{n.r(i),n.d(i,{assets:()=>p,contentTitle:()=>d,default:()=>u,frontMatter:()=>l,metadata:()=>h,toc:()=>m});var r=n(5893),s=n(1151);const a=n.p+"assets/images/tropheart-ddaa1878f702dfbcdbaddf22c6cca461.png",t=n.p+"assets/images/biotypes-77b023eb14c0cf1b8acd935df0630c25.png",o=n.p+"assets/images/her2-f2659188c692c0806bbf7d6a0a6df5e6.png",c=n.p+"assets/images/disbio-37a156539ad6d67af0ab4086952644dd.png",l={title:"Biomarkers as Beacons of Health and Disease",sidebar_position:1},d=void 0,h={id:"Life Sciences/Biomarkers/biomarkers",title:"Biomarkers as Beacons of Health and Disease",description:"Download the PDF version here.",source:"@site/docs/Life Sciences/Biomarkers/biomarkers.md",sourceDirName:"Life Sciences/Biomarkers",slug:"/Life Sciences/Biomarkers/",permalink:"/KershiaMukoro.github.io/docs/Life Sciences/Biomarkers/",draft:!1,unlisted:!1,tags:[],version:"current",sidebarPosition:1,frontMatter:{title:"Biomarkers as Beacons of Health and Disease",sidebar_position:1},sidebar:"tutorialSidebar",previous:{title:"Biomarkers as Beacons of Health and Disease",permalink:"/KershiaMukoro.github.io/docs/category/biomarkers-as-beacons-of-health-and-disease"},next:{title:"Article: Exploring the Complex Eitology of COPD",permalink:"/KershiaMukoro.github.io/docs/category/article-exploring-the-complex-eitology-of-copd"}},p={},m=[{value:"The Search for Biomarkers",id:"the-search-for-biomarkers",level:2},{value:"The Spectrum of Biomarkers and Therapeutic Uses",id:"the-spectrum-of-biomarkers-and-therapeutic-uses",level:2},{value:"Real-World Applications of Biomarkers",id:"real-world-applications-of-biomarkers",level:2},{value:"Emerging Trends",id:"emerging-trends",level:2},{value:"Technological Innovations in Biomarker Research",id:"technological-innovations-in-biomarker-research",level:2},{value:"Challenges and Limitations in Biomarker Development",id:"challenges-and-limitations-in-biomarker-development",level:2},{value:"Patient Perspectives",id:"patient-perspectives",level:2},{value:"Realizing the Future of Medicine Through Biomarkers",id:"realizing-the-future-of-medicine-through-biomarkers",level:2}];function g(e){const i={a:"a",admonition:"admonition",em:"em",h2:"h2",li:"li",ol:"ol",p:"p",strong:"strong",ul:"ul",...(0,s.a)(),...e.components},{Details:l}=i;return l||function(e,i){throw new Error("Expected "+(i?"component":"object")+" `"+e+"` to be defined: you likely forgot to import, pass, or provide it.")}("Details",!0),(0,r.jsxs)(r.Fragment,{children:[(0,r.jsx)(i.admonition,{title:"Note",type:"tip",children:(0,r.jsx)(i.p,{children:(0,r.jsx)(i.a,{target:"_blank","data-noBrokenLinkCheck":!0,href:n(2258).Z+"",children:(0,r.jsx)(i.em,{children:(0,r.jsx)(i.strong,{children:"Download the PDF version here."})})})})}),"\n",(0,r.jsx)(i.p,{children:"Biomarkers serve as beacons in the complex landscape of health and disease, guiding both patients and healthcare providers. A biomarker, short for biological marker, is a measurable indicator of biological conditions or trends. Biomarkers act like signals illuminating the body's inner workings, indicating normal processes, the presence of disease, or responses to treatments. Think of a biomarker as a clue or a sign that scientists and doctors can track, measure, and analyze to understand a person's health better or the presence and progression of a disease. By tapping into this vital information, biomarkers can inform diagnosis, predict outcomes, and even guide the effectiveness of treatment plans."}),"\n",(0,r.jsx)(i.h2,{id:"the-search-for-biomarkers",children:"The Search for Biomarkers"}),"\n",(0,r.jsx)(i.p,{children:"The discovery of biomarkers is a meticulous process that blends scientific curiosity with advanced technology. To uncover these vital signs of health and disease, researchers follow a series of methodical steps:"}),"\n",(0,r.jsx)(i.admonition,{title:"Steps in Biomarker Discovery",type:"note",children:(0,r.jsx)("img",{src:c,alt:"Biomarker Research",style:{width:600}})}),"\n",(0,r.jsxs)(l,{children:[(0,r.jsx)("summary",{children:(0,r.jsx)(i.strong,{children:"Discovery"})}),(0,r.jsx)(i.p,{children:"The journey begins with a hypothesis. Scientists collect and compare samples from healthy individuals and those with specific diseases, searching for any biological differences that stand out. This could be anything from a unique protein found in the blood of patients with heart disease to a genetic mutation present in individuals with a particular type of cancer."}),(0,r.jsxs)(l,{children:[(0,r.jsx)("summary",{children:(0,r.jsx)(i.strong,{children:"Analysis"})}),(0,r.jsx)(i.p,{children:"When a potential biomarker is identified, it is put to the test in various conditions and populations to ensure it is consistently associated with the disease. Advanced software is often used to handle the immense amount of data this research generates, looking for patterns that confirm the biomarker's relevance."}),(0,r.jsxs)(l,{children:[(0,r.jsx)("summary",{children:(0,r.jsx)(i.strong,{children:"Clinical Correlation"})}),(0,r.jsx)(i.p,{children:"The most promising biomarkers then move into clinical trials, where they are tested in a larger, more varied group of people to validate their accuracy and reliability. Here, scientists determine whether the biomarker can truly predict or diagnose a disease in the broader population, outside the controlled settings of initial research."}),(0,r.jsxs)(l,{children:[(0,r.jsx)("summary",{children:(0,r.jsx)(i.strong,{children:"Refinement and Approval"})}),(0,r.jsx)(i.p,{children:"Before a biomarker can be used in healthcare settings, it must undergo a rigorous process of refinement and regulatory approval. This ensures the biomarker is both safe and effective for public use."})]})]})]})]}),"\n",(0,r.jsx)(i.p,{children:"Throughout this process, the goal is to find biomarkers that can be easily and reliably measured, providing a clear signal of a person's health status. For patients and healthcare providers, understanding how biomarkers are discovered helps in appreciating the science behind medical tests and treatments, and in recognizing the role these markers play in tailoring healthcare to individual needs."}),"\n",(0,r.jsx)(i.h2,{id:"the-spectrum-of-biomarkers-and-therapeutic-uses",children:"The Spectrum of Biomarkers and Therapeutic Uses"}),"\n",(0,r.jsx)(i.p,{children:"Biomarkers are diverse and multifaceted, each type providing unique insights into various aspects of health and disease. Understanding the different types of biomarkers and their specific applications can significantly enhance how diseases are detected, monitored, and treated. This section will explore the primary categories of biomarkers, shedding light on their role in advancing medical science and improving patient care."}),"\n",(0,r.jsx)(i.admonition,{title:"Types of Biomarkers",type:"note",children:(0,r.jsx)("img",{src:t,alt:"Types of Biomarkers",style:{width:700}})}),"\n",(0,r.jsx)(i.p,{children:(0,r.jsx)(i.strong,{children:"Types of Biomarkers:"})}),"\n",(0,r.jsxs)(i.ol,{children:["\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Diagnostic Biomarkers:"})," Diagnostic biomarkers help in identifying the presence of a particular disease in an individual. These are often used in medical tests to confirm or rule out conditions, making them essential for accurate and timely diagnosis."]}),"\n"]}),"\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Prognostic Biomarkers:"})," Prognostic biomarkers provide information about the likely course of a disease in an individual. They can predict the progression of a disease, such as indicating how aggressive a cancer might be or the likelihood of recovery in heart disease patients."]}),"\n"]}),"\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Predictive Biomarkers:"})," Predictive biomarkers are used to determine the likelihood of response to a particular treatment. They are crucial in the field of personalized medicine, as they help tailor treatments to individuals based on their unique biomarker profiles, enhancing efficacy and minimizing side effects."]}),"\n"]}),"\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Pharmacodynamic Biomarkers:"})," These biomarkers indicate whether a drug is having its intended effect in a patient and at what dose. Pharmacodynamic biomarkers are invaluable in drug development and ongoing patient care, ensuring that treatments are effective and adjusted as needed."]}),"\n"]}),"\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Surrogate Biomarkers:"})," A type of biomarker used as a substitute for a clinically meaningful endpoint that directly measures how a patient feels, functions, or survives. These biomarkers are intended to predict the effects of a therapeutic intervention, often before definitive clinical outcomes can be observed. Surrogate biomarkers are particularly valuable in clinical trials and therapeutic development because they can provide earlier indications of whether a treatment is effective, potentially speeding up the process of drug approval and patient access to new therapies."]}),"\n"]}),"\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Safety Biomarkers:"})," Safety biomarkers signal the potential toxic effects of a treatment or exposure to certain substances. They are vital in clinical trials and environmental health, providing early warnings that can prevent harm and guide decision-making about the safety of a drug or environmental agent.\r\nEach type of biomarker plays a pivotal role in the landscape of healthcare and research, contributing to a deeper understanding of diseases and more personalized approaches to health management."]}),"\n"]}),"\n"]}),"\n",(0,r.jsx)(i.h2,{id:"real-world-applications-of-biomarkers",children:"Real-World Applications of Biomarkers"}),"\n",(0,r.jsx)(i.p,{children:"Explore how biomarkers have been successfully applied in real-world scenarios, illustrating their impact on diagnostics, treatment, and patient care."}),"\n",(0,r.jsx)(i.p,{children:(0,r.jsx)(i.strong,{children:"Use of Troponin for Heart Attack Diagnosis"})}),"\n",(0,r.jsx)(i.admonition,{title:"Cardiac Biomarkers",type:"note",children:(0,r.jsx)("img",{src:a,alt:"Cardiac Biomarkers",style:{width:500}})}),"\n",(0,r.jsxs)(i.ul,{children:["\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Background:"})," Troponin is a protein released into the bloodstream when heart muscle is damaged. It is an essential biomarker for diagnosing myocardial infarction (heart attack)."]}),"\n"]}),"\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Application:"})," Emergency departments globally use troponin tests as part of the diagnostic process when a heart attack is suspected. The rapid detection of elevated troponin levels enables immediate and appropriate therapeutic intervention."]}),"\n"]}),"\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Outcome:"})," The use of troponin tests has significantly improved the speed and accuracy of heart attack diagnosis, leading to quicker treatment initiation and better patient outcomes."]}),"\n"]}),"\n"]}),"\n",(0,r.jsx)(i.p,{children:(0,r.jsx)(i.strong,{children:"HER2 Protein in Breast Cancer"})}),"\n",(0,r.jsxs)(i.admonition,{title:"Overexpression of HER2",type:"note",children:[(0,r.jsx)("img",{src:o,alt:"Overexpression of HER2",style:{width:800}}),(0,r.jsx)("figcaption",{children:(0,r.jsxs)("sub",{children:["Source: ",(0,r.jsx)(i.a,{href:"https://www.knowyourbiomarker.org/biomarkers/her2",children:"https://www.knowyourbiomarker.org/biomarkers/her2"})]})})]}),"\n",(0,r.jsxs)(i.ul,{children:["\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Background:"})," HER2 is a protein that promotes the growth of cancer cells. In about 20% of breast cancer cases, this protein is present in high amounts, and its detection is crucial for determining treatment strategy."]}),"\n"]}),"\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Application:"})," Testing for HER2 expression helps identify patients who will benefit from HER2-targeted therapies, such as trastuzumab (Herceptin), which specifically attacks HER2-positive cancer cells."]}),"\n"]}),"\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Outcome:"})," Patients with HER2-positive breast cancer who receive targeted therapy generally have a much better prognosis, with significant reductions in recurrence and mortality rates."]}),"\n"]}),"\n"]}),"\n",(0,r.jsx)(i.h2,{id:"emerging-trends",children:"Emerging Trends"}),"\n",(0,r.jsx)(i.p,{children:"Trends emerging in biomarker research promise to revolutionize the early detection of diseases and the personalization of patient care, utilizing breakthroughs in genetics and artificial intelligence."}),"\n",(0,r.jsx)(i.p,{children:(0,r.jsx)(i.strong,{children:"Genetic Biomarkers for Alzheimer's Disease"})}),"\n",(0,r.jsxs)(i.ul,{children:["\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Research Focus:"})," Researchers are identifying specific genetic markers that predict the risk of Alzheimer's disease. These biomarkers can be present decades before symptoms arise."]}),"\n"]}),"\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Potential Impact:"})," Early identification allows for the possibility of delaying or preventing the onset of Alzheimer's through lifestyle changes, medication, or participation in clinical trials."]}),"\n"]}),"\n"]}),"\n",(0,r.jsx)(i.p,{children:(0,r.jsx)(i.strong,{children:"Artificial Intelligence in Biomarker Discovery"})}),"\n",(0,r.jsxs)(i.ul,{children:["\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Research Focus:"})," AI is increasingly used to sift through vast amounts of medical data to discover new biomarkers. Machine learning algorithms can identify patterns that human researchers may overlook."]}),"\n"]}),"\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Potential Impact:"})," AI accelerates biomarker discovery, enhances diagnostic processes, and optimizes treatment protocols, making medical care more effective and efficient."]}),"\n"]}),"\n"]}),"\n",(0,r.jsx)(i.h2,{id:"technological-innovations-in-biomarker-research",children:"Technological Innovations in Biomarker Research"}),"\n",(0,r.jsx)(i.p,{children:"The field of biomarker research is rapidly evolving, driven by groundbreaking technologies that enhance the discovery and utility of biomarkers. These innovations not only improve diagnostic accuracy but also open new avenues for personalized medicine."}),"\n",(0,r.jsx)(i.p,{children:(0,r.jsx)(i.strong,{children:"CRISPR and Gene Editing"})}),"\n",(0,r.jsxs)(i.ul,{children:["\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Technology:"})," CRISPR and other gene-editing tools allow researchers to edit parts of the genome with high precision. This capability is crucial for understanding genetic biomarkers and their roles in diseases."]}),"\n"]}),"\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Impact:"})," Gene editing is revolutionizing the way diseases are studied and treated, enabling the development of more targeted therapies based on specific biomarkers."]}),"\n"]}),"\n"]}),"\n",(0,r.jsx)(i.p,{children:(0,r.jsx)(i.strong,{children:"Next-Generation Sequencing (NGS)"})}),"\n",(0,r.jsxs)(i.ul,{children:["\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Technology:"})," NGS technologies provide a comprehensive analysis of genetic material, allowing for the rapid sequencing of DNA and RNA. This technology can identify genetic variations and mutations that serve as biomarkers."]}),"\n"]}),"\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Impact:"})," NGS accelerates the identification of biomarkers, reduces costs, and enhances the personalization of healthcare by providing detailed genetic profiles."]}),"\n"]}),"\n"]}),"\n",(0,r.jsx)(i.p,{children:(0,r.jsx)(i.strong,{children:"Wearable Health Technology"})}),"\n",(0,r.jsxs)(i.ul,{children:["\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Technology:"})," Advanced wearables and mobile devices are increasingly capable of monitoring and collecting health-related data, including physiological biomarkers."]}),"\n"]}),"\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Impact:"})," These devices make it possible to continuously monitor health indicators in real-time, providing a dynamic view of an individual's health and improving disease prediction and management."]}),"\n"]}),"\n"]}),"\n",(0,r.jsx)(i.h2,{id:"challenges-and-limitations-in-biomarker-development",children:"Challenges and Limitations in Biomarker Development"}),"\n",(0,r.jsx)(i.p,{children:"Despite their potential, the development of biomarkers faces several significant challenges that can impact their clinical utility and acceptance."}),"\n",(0,r.jsx)(i.p,{children:(0,r.jsx)(i.strong,{children:"Specificity and Sensitivity"})}),"\n",(0,r.jsxs)(i.ul,{children:["\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Challenge:"})," High specificity and sensitivity are crucial for effective biomarkers to ensure they accurately detect a condition without false positives or negatives."]}),"\n"]}),"\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Impact:"})," Challenges with specificity and sensitivity can lead to misdiagnoses, resulting in inappropriate treatments that can harm patients."]}),"\n"]}),"\n"]}),"\n",(0,r.jsx)(i.p,{children:(0,r.jsx)(i.strong,{children:"Ethical and Regulatory Concerns"})}),"\n",(0,r.jsxs)(i.ul,{children:["\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Challenge:"})," The use of genetic biomarkers, in particular, raises concerns about privacy, consent, and potential discrimination."]}),"\n"]}),"\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Impact:"})," There is a need for stringent ethical guidelines and robust regulatory oversight to manage these issues, ensuring patient rights are protected while fostering scientific advancement."]}),"\n"]}),"\n"]}),"\n",(0,r.jsx)(i.p,{children:(0,r.jsx)(i.strong,{children:"Regulatory Challenges"})}),"\n",(0,r.jsxs)(i.ul,{children:["\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Challenge:"})," The approval process for new biomarkers can be complex and lengthy, involving multiple stages of validation and compliance with international standards."]}),"\n"]}),"\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Impact:"})," This complexity can delay the availability of important new diagnostics and treatments, affecting patient care."]}),"\n"]}),"\n"]}),"\n",(0,r.jsx)(i.h2,{id:"patient-perspectives",children:"Patient Perspectives"}),"\n",(0,r.jsx)(i.p,{children:"Understanding biomarkers from the patient's perspective is crucial for integrating these tools into healthcare systems in a way that respects and enhances patient autonomy and involvement."}),"\n",(0,r.jsx)(i.p,{children:(0,r.jsx)(i.strong,{children:"Patient Education and Involvement"})}),"\n",(0,r.jsxs)(i.ul,{children:["\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Importance:"})," Comprehensive education on biomarkers helps patients make informed decisions about their healthcare, enhancing their engagement and satisfaction with the treatment process."]}),"\n"]}),"\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Benefit:"})," An informed patient is more likely to adhere to treatment protocols and engage actively with healthcare providers, improving overall health outcomes."]}),"\n"]}),"\n"]}),"\n",(0,r.jsx)(i.p,{children:(0,r.jsx)(i.strong,{children:"Privacy and Data Security"})}),"\n",(0,r.jsxs)(i.ul,{children:["\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Concern:"})," With the increase in genetic testing and personalized medicine, patients are understandably concerned about the security and use of their personal health information."]}),"\n"]}),"\n",(0,r.jsxs)(i.li,{children:["\n",(0,r.jsxs)(i.p,{children:[(0,r.jsx)(i.strong,{children:"Addressing Concerns:"})," Healthcare providers must ensure that all biomarker data is handled securely, with clear communication to patients about how their data is used and who has access to it."]}),"\n"]}),"\n"]}),"\n",(0,r.jsx)(i.h2,{id:"realizing-the-future-of-medicine-through-biomarkers",children:"Realizing the Future of Medicine Through Biomarkers"}),"\n",(0,r.jsx)(i.p,{children:"In the complex field of healthcare, biomarkers stand out as essential tools that bridge cutting-edge research with practical clinical applications. They not only enhance the accuracy of diagnoses and the effectiveness of treatments but also pave the way for personalized medicine, with treatments tailored to individual genetic and molecular profiles. As research continues to advance, the potential for biomarkers to revolutionize disease management and patient care grows, promising a future where medicine is more predictive, preventive, and personalized. This exploration of biomarkers not only highlights their diverse roles but also underscores the importance of ongoing research and dialogue among scientists, clinicians, and patients to fully realize their potential in improving health outcomes."}),"\n",(0,r.jsxs)(l,{children:[(0,r.jsx)("summary",{children:(0,r.jsx)(i.strong,{children:"References"})}),(0,r.jsxs)(i.ol,{children:["\n",(0,r.jsx)(i.li,{children:"Albert MA. Biomarkers and Heart Disease. J Clin Sleep Med. Published online October 15, 2011. doi:10.5664/JCSM.1342."}),"\n",(0,r.jsx)(i.li,{children:"Dugan J. Biomarkers: An important clinical assessment tool. AJN The American Journal of Nursing. 2012;112(9):52-58. doi:10.1097/01.NAJ.0000418920.07835.2b"}),"\n",(0,r.jsx)(i.li,{children:"Griffiths HR, M\xf8ller L, Bartosz G, et al. Biomarkers. In: Molecular Aspects of Medicine. February 2002;23(1-3):101-208, chapter 3. doi:10.1016/S0098-2997(02)00017-1."}),"\n",(0,r.jsxs)(i.li,{children:["Meditrial. Clinical Trials: How Biomarkers Help Research. Meditrial website. Published September 2022. Accessed April 20, 2024. ",(0,r.jsx)(i.a,{href:"https://www.meditrial.net/2022/09/clinical-trials-how-biomarkers-help-research/",children:"https://www.meditrial.net/2022/09/clinical-trials-how-biomarkers-help-research/"})]}),"\n",(0,r.jsxs)(i.li,{children:["National Institute of Environmental Health Sciences. Biomarkers. NIEHS website. Accessed April 20, 2024. ",(0,r.jsx)(i.a,{href:"https://www.niehs.nih.gov/health/topics/science/biomarkers",children:"https://www.niehs.nih.gov/health/topics/science/biomarkers"})]}),"\n",(0,r.jsx)(i.li,{children:"Poste G. Bring on the biomarkers. Nature. 2011;469(7329):156-157. doi:10.1038/469156a"}),"\n",(0,r.jsx)(i.li,{children:"Savic-Radojevic A, Pljesa-Ercegovac M, Matic M, Simic D, Radovanovic S, Simic T. Novel Biomarkers of Heart Failure. In: Advances in Clinical Chemistry. 2017;79:93-152. doi:10.1016/bs.acc.2016.09.002."}),"\n",(0,r.jsxs)(i.li,{children:["U.S. Food and Drug Administration. What Are Biomarkers and Why Are They Important Transcript. FDA website. Accessed April 20, 2024. ",(0,r.jsx)(i.a,{href:"https://www.fda.gov/drugs/biomarker-qualification-program/what-are-biomarkers-and-why-are-they-important-transcript",children:"https://www.fda.gov/drugs/biomarker-qualification-program/what-are-biomarkers-and-why-are-they-important-transcript"})]}),"\n",(0,r.jsx)(i.li,{children:"van Kimmenade RRJ, Januzzi JL Jr. Emerging Biomarkers in Heart Failure. Clin Chem. 2012;58(1):127-138. doi:10.1373/clinchem.2011.165720."}),"\n"]})]})]})}function u(e={}){const{wrapper:i}={...(0,s.a)(),...e.components};return i?(0,r.jsx)(i,{...e,children:(0,r.jsx)(g,{...e})}):g(e)}},2258:(e,i,n)=>{n.d(i,{Z:()=>r});const r=n.p+"assets/files/Biomarker_Discovery-4eb224f7727a6f38e46646315ca0a469.pdf"},1151:(e,i,n)=>{n.d(i,{Z:()=>o,a:()=>t});var r=n(7294);const s={},a=r.createContext(s);function t(e){const i=r.useContext(a);return r.useMemo((function(){return"function"==typeof e?e(i):{...i,...e}}),[i,e])}function o(e){let i;return i=e.disableParentContext?"function"==typeof e.components?e.components(s):e.components||s:t(e.components),r.createElement(a.Provider,{value:i},e.children)}}}]);